Praxis Precision Medicines earnings were -$182.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PRAX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$58.7M, up 13% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRAX reported annual earnings of -$182.8M, with 48.3% growth. The next PRAX earnings date is May 12, 2025.
Praxis Precision Medicines Earnings Reports & History FAQ
What were Praxis Precision Medicines's earnings last quarter?
On PRAX's earnings call on Invalid Date, Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 2024 earnings per share (EPS) of -$3.00, up 53.06% year over year. Total PRAX earnings for the quarter were -$58.68 million. In the same quarter last year, Praxis Precision Medicines's earnings per share (EPS) was -$1.96.
When does Praxis Precision Medicines report earnings?
The next PRAX earnings call is Invalid Date. Add PRAX to your watchlist to be reminded of Praxis Precision Medicines's next earnings date.
Is Praxis Precision Medicines profitable or losing money?
As of the last Praxis Precision Medicines earnings report, Praxis Precision Medicines is currently losing money. Praxis Precision Medicines's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$182.82 million, a 48.3% increase year over year.
What was PRAX's earnings growth in the past year?
As of Praxis Precision Medicines's earnings date in Invalid Date, Praxis Precision Medicines's earnings has grown year over year. PRAX earnings in the past year totalled -$182.82 million.
What are Praxis Precision Medicines's earnings expectations?
The current EPS estimate for Praxis Precision Medicines's earnings report in Invalid Date is -$2.07.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.